DrugDashboards

zidesamtinib

zidesamtinib · ZIDESAMTINIB 100 mg/1 · Tablet, Film Coated · Patheon Inc.

NDC 63285-0936-30 · 100 BOTTLE in 1 CASE / 30 TABLET, FILM COATED in 1 BOTTLE · DRUG FOR FURTHER PROCESSING · View full market →

Bulk ingredient — not a finished product

This NDC is a raw material (drug for further processing) sold to drug manufacturers or compounders, not a product pharmacies dispense. Retail pricing, TE codes, fragility scores, and shortage reports don't apply to bulk listings — those attach to finished products made from this ingredient.

Medicare Part D

This is a bulk ingredient, not a dispensable product — it is a raw material sold to manufacturers and compounders, so no plan prices it.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Regulatory

Application
TE code
Approval date
Patents / exclusivity

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of zidesamtinib (Tablet, Film Coated)

LabelerStrengthFirst seenLast seen
Patheon Inc.ZIDESAMTINIB 100 mg/1Jul 29, 2026Sep 2, 2026
Patheon Inc.ZIDESAMTINIB 25 mg/1Jul 29, 2026Sep 2, 2026
Nuvalent, Inc.ZIDESAMTINIB 100 mg/1Jul 31, 2026Aug 28, 2026
Nuvalent, Inc.ZIDESAMTINIB 25 mg/1Jul 31, 2026Aug 28, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "zidesamtinib — NDC 63285-0936-30," retrieved September 3, 2026, https://drugdashboards.com/drug/63285093630.

Free to cite with attribution — see how the data is put together.